The financial generosity of the pharmaceutical industry to provide funding for medical education tempts a compromise of professional standards and ethics.

In April 2002, many pharmaceutical companies adopted PhRMA code, an attempt to self-regulate the pharmaceutical industry's marketing to physicians and other health care professionals.

Streamlining US health care business has raised unique privacy concerns. Bills and explanations of benefits contain protected health information that could be disclosed to someone other than the patient.

Private equity investments in health care have grown to over $750 billion in the past decade and include every segment of the US health sector.

Upcoding and misrepresenting clinical information constitute fraud, cost a lot, and can result in patient harm and unnecessary procedures and prescriptions.